FDA favors first conventional glucagon for injection to treat extreme hypoglycemia Kumar Jeetendra | December 29, 2020 Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packed in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus. The drug is also indicated as a diagnostic aid in the radiologic examination of …
First smart speaker for contactless observing of both reguilar and unpredictable heartbeats Kumar Jeetendra | March 9, 2021 Wise speakers, such as Amazon Echo and Google Home, have proven adept at monitoring certain health care issues at home. By way of instance, researchers at the University of Washington have shown that these devices can detect cardiac arrests or track babies breathing. But what about monitoring something even smaller: the moment motion of individual …
Central amygdala micro circuits assume dynamic part in regulation of dread responses Kumar Jeetendra | July 17, 2021 Because they can be used to treat anxiety disorders, the brain mechanisms that suppress fear reactions have been a focus of much attention. Although we have a good understanding of the brain regions that are activated when fear is experienced, it remains to be largely unknown how fear reactions can be suppressed. Researchers from the …
Researchers develop AI-based model to analyze cardiovascular illnesses and diabetes Kumar Jeetendra | August 14, 2021 Scientists from South Ural State University (SUSU), along with colleagues from France, Spain, and Egypt, have created a model that can be used to diagnose cardiovascular diseases and diabetes more effectively using artificial intelligence and Internet of Things technology. The Russian Ministry of Science and Higher Education supported this work. In an article published in …